Navigation Links
Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
Date:10/11/2007

OXFORD, England, October 11 /PRNewswire/ -- Oxford Genome Sciences (UK) Ltd "OGeS" announces today that it has further strengthened its Scientific Advisory Board (SAB) with the appointment of Sir Walter Bodmer, currently Head of the Cancer and Immunogenetics Laboratory in the Weatherall Institute of Molecular Medicine at the University of Oxford, which is actively researching the fundamental genetic and biological changes which lead to the development of colorectal cancer.

In addition to the SAB appointment, OGeS and Sir Walter's laboratory will collaborate on the evaluation of OGeS cancer drug development candidates in the area of colorectal cancer.

Prior to taking up his current position, Sir Walter Bodmer was the Director General of the Imperial Cancer Research Fund, London, a position he assumed after having been the Fund's Director of Research for 12 years. Before joining the Imperial Cancer Research Fund, he was the Professor of Genetics at the University of Oxford. Dr Bodmer moved to Oxford University from Stanford University where he was a Professor in the Department of Genetics.

Dr Bodmer, who has developed models for population genetics, worked extensively on the HLA system and the use of somatic cell hybrids for human linkage studies, received his Ph.D. in Genetics in 1959 from the University of Cambridge. He became a fellow of the Royal Society in 1974, a foreign member of the US national Academy of Sciences in 1981 and was knighted in 1986 for his contributions to science.

Dr Christian Rohlff, CEO of OGeS commenting on today's announcement said:

"I am delighted that someone of Walter's scientific standing has agreed to join our Scientific Advisory Board. I am sure his broad ranging experience in genetics and biology and his current work in the field of colorectal cancer will allow him to make an important contribution to OGeS as we continue to further develop our position in the exciting field of personalised medicin
'/>"/>

SOURCE Oxford Genome Sciences
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Schneider National exec joins TrafficCast board
3. Doyle joins governors in support of stem cell bill
4. Genomics researcher Hood joins NimbleGen board
5. Fergus joins Baird Venture Partners, Caden Bio
6. Meier joins Broadlook Technologies as COO
7. Prodesse joins forces with Invitrogen
8. Wisconsin joins price-fixing suit vs. D-RAM makers
9. Napier joins board of Third Wave Technologies
10. Schmidt rejoins Renaissance Learning
11. Tommy Thompson joins drug company as advisor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...IS and NORTH VANCOUVER, British Columbia, Dec. 1 /...holly owned subsidiary of The Dow Chemical Company...day announced the signing of a research and commer...des Dow AgroSciences with access to Agrisoma,s pro... an exclusive basis in major food crops, and on a ...
(Date:12/1/2009)...SCO, Dec. 1 Medizone Int...ced today that in tests involving its proprietary ..."6 log" decontamination barriers, this time with t...dium difficile and Bacillis subtilis. These result...y potent sporicidal technology. "The implications ...
(Date:12/1/2009)...Dec. 1 GeoVax Labs, Inc...Atlanta-based, biopharmaceutical company developin...an Immunodeficiency Virus) and other infectious ag...ay. ,, "Today is the 21st World AIDS Day and as...ht with the HIV/AIDS pandemic, we remain focused a...
(Date:12/1/2009)... A new clinical study presented to the American ...-dimensional (3-D) automated ultrasound follicle m...n vitro fertilization (IVF) cycle is effective and...t of the follicles. , Gur...ertility Center of Chicago has just completed rese...
Breaking Biology Technology:Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3
...eMed, Inc.,(Nasdaq: ENMD ) a clinical-stage pharm...treatment of cancer and inflammatory diseases, tod...ief Executive Officer, will,present a Corporate ov...tech Industry Conference, to be held at the Millen... 2008. Mr. Burns, presentation is scheduled for,Th...
... Senesco,Technologies, Inc. (the "Company") (Amex:...the American Stock Exchange ("AMEX") stating that ...iciencies referenced in the AMEX,s,letters dated J...is based,upon a review of publicly available infor...urities and Exchange Commission filings., Senesco...
...false and misleading information, SOUTH SAN FRANC...xGen,Inc. (OTC Bulletin Board: VXGN.OB), (Logo...XGENLOGO ), Dear Stockholders, On March 19th, Me...VaxGen, issued a press release entitled "MedCap Ur... biotechnologies". We believe this release, one of...
Other Biology Technology:EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference 2Senesco Technologies Regains Compliance With Amex's Continued Listing Requirements 2Senesco Technologies Regains Compliance With Amex's Continued Listing Requirements 3VaxGen Issues Rebuttal to MedCap Letter 2VaxGen Issues Rebuttal to MedCap Letter 3VaxGen Issues Rebuttal to MedCap Letter 4VaxGen Issues Rebuttal to MedCap Letter 5VaxGen Issues Rebuttal to MedCap Letter 6VaxGen Issues Rebuttal to MedCap Letter 7VaxGen Issues Rebuttal to MedCap Letter 8VaxGen Issues Rebuttal to MedCap Letter 9VaxGen Issues Rebuttal to MedCap Letter 10VaxGen Issues Rebuttal to MedCap Letter 11
(Date:11/30/2009)... inaugural Global Conference on Systems & Enterpri...ington, DC, focuses on the convergence of complex ...portance to society. , The goal of the confe... around targeted complex systems, examined by doma...des Critical Infrastructure Systems, including Int...
(Date:11/30/2009)...the stress of seeing your extended family over the...search report in the December 2009 print issue of ...eukbio.org ) shows that you might be right. Here,s...lead to entirely new treatments that help keep aut... under control. That,s because researchers from th...
(Date:11/26/2009)...ressive antlers, red deer have been caught in the ...ers are much more than decorative. They are lethal...John Currey, from The University of York, UK, has ...e for over half a century and has become fascinate... long-standing collaboration with Tomas Landete-Ca...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 1Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 2Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 33SBio Inc to Report 2009 Third Quarter Earnings on November 12 2009 14616 13SBio Inc to Report 2009 Third Quarter Earnings on November 12 2009 14616 2Adding tools against breast tumors 60167 1
... Premature babies are subject to a host of threats...tudy published in the January 2008 issue of the Am...hers from the University of AlabamaBirmingham Medi...dicine found that genital mycoplasmas are a freque...nates born between 23 and 32 weeks of gestation ha...
... Recent inquiry into variation and evolution of re...d exciting and ground-breaking work within the pla...nal Journal of Plant Sciences, leading botanist Sp... together in a single volume some of the most comp...most growth: flowers and pollination, mating patte...
... CAMBRIDGE, Mass.--MIT researchers have uncovered ...ect birds and humans, a discovery that could help ...ins and aid in the development of vaccines against...hat a virus,s ability to infect humans depends on ...tor on the surface of human respiratory cells. , ...
Other Biology News:Bacterial infections in premature babies more common than previously realized 2A special issue of the International Journal of Plant Sciences 2A special issue of the International Journal of Plant Sciences 3MIT finds key to avian flu in humans 2MIT finds key to avian flu in humans 3
GIBCO MEM Non-Essential Amino Acids Solution 10 mM (100X), liquid from Invitrogen
...kers, 37 kBq, 1 uCi. Carbon-14 radiolabelled marke...f the sample on Western blots.The Rainbow-labeled ...ation in the gel and on the blot.The specific acti... is 0.37-3.7 MBq/mg (10-100 uCi/mg) or 185 kBq/ml ...
Amino Acid Mixture Minus Leucine from Promega
Bacterial Strain NM522, Glycerol Stock from Promega
Biology Products: